Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12


A recombinant anchorless respiratory syncytial virus (RSV) fusion (F) protein/monophosphoryl lipid A (MPL) vaccine protects against RSV-induced replication and lung pathology.

Blanco JC, Boukhvalova MS, Pletneva LM, Shirey KA, Vogel SN.

Vaccine. 2014 Mar 14;32(13):1495-500. doi: 10.1016/j.vaccine.2013.11.032. Epub 2013 Nov 16.


Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.

Quan FS, Kim Y, Lee S, Yi H, Kang SM, Bozja J, Moore ML, Compans RW.

J Infect Dis. 2011 Oct 1;204(7):987-95. doi: 10.1093/infdis/jir474. Erratum in: J Infect Dis. 2012 Feb;205(3):520.


RSV fusion (F) protein DNA vaccine provides partial protection against viral infection.

Wu H, Dennis VA, Pillai SR, Singh SR.

Virus Res. 2009 Oct;145(1):39-47. doi: 10.1016/j.virusres.2009.06.012. Epub 2009 Jun 21.


Mouse models for the study of mucosal vaccination against otitis media.

Sabirov A, Metzger DW.

Vaccine. 2008 Mar 17;26(12):1501-24. doi: 10.1016/j.vaccine.2008.01.029. Epub 2008 Feb 4. Review.


Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model.

Singh SR, Dennis VA, Carter CL, Pillai SR, Jefferson A, Sahi SV, Moore EG.

Vaccine. 2007 Aug 14;25(33):6211-23. Epub 2007 Jun 26.


Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa.

Arnold H, Bumann D, Felies M, Gewecke B, Sörensen M, Gessner JE, Freihorst J, von Specht BU, Baumann U.

Infect Immun. 2004 Nov;72(11):6546-53.


Nasal vaccination induces protective immunity without immunopathology.

Hussell T, Humphreys IR.

Clin Exp Immunol. 2002 Dec;130(3):359-62. No abstract available.


Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae.

Goetsch L, Gonzalez A, Plotnicky-Gilquin H, Haeuw JF, Aubry JP, Beck A, Bonnefoy JY, Corvaïa N.

Infect Immun. 2001 Oct;69(10):6434-44.


Respiratory syncytial virus infection in adults.

Falsey AR, Walsh EE.

Clin Microbiol Rev. 2000 Jul;13(3):371-84. Review.


Respiratory syncytial virus vaccines.

Dudas RA, Karron RA.

Clin Microbiol Rev. 1998 Jul;11(3):430-9. Review.


The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice.

Ferrero RL, Thiberge JM, Kansau I, Wuscher N, Huerre M, Labigne A.

Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6499-503.

Supplemental Content

Support Center